Evidence map›Paper›PMID 41791379›Full record

ArticleCancer cell2026

A tumor-associated photoreceptor signature unifies distinct central nervous system malignancies.

Brian L Gudenas, Shiekh Tanveer Ahmad, Bernhard Englinger, Anthony P Y Liu, Miao Zhao, Leena Paul, Jennifer Hadley, Yiran Li, Melissa Batts, Priya Mittal and 21 more

Abstract read
In one paragraph

Article in Cancer cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Kill three birds with one stone.Nature reviews. Cancer · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Brian L GudenasCenter of Excellence in Neuro-Oncology Sciences (CENOS), St. Jude Children's Research Hospital, Memphis, TN, USA; Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Shiekh Tanveer AhmadCenter of Excellence in Neuro-Oncology Sciences (CENOS), St. Jude Children's Research Hospital, Memphis, TN, USA; Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Bernhard EnglingerDana-Farber/Boston Children's Cancer and Blood Disorders Center; Harvard Medical School, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Center for Cancer Research and Comprehensive Cancer Center, Medical University Vienna, Vienna, Austria.
Anthony P Y LiuCenter of Excellence in Neuro-Oncology Sciences (CENOS), St. Jude Children's Research Hospital, Memphis, TN, USA; Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA; Division of Haematology/Oncology, The Hospital for Sick Children (SickKids), Toronto, ON M5G 1E8, Canada.
Miao ZhaoDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
Leena PaulCenter of Excellence in Neuro-Oncology Sciences (CENOS), St. Jude Children's Research Hospital, Memphis, TN, USA; Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Jennifer HadleyCenter of Excellence in Neuro-Oncology Sciences (CENOS), St. Jude Children's Research Hospital, Memphis, TN, USA; Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Yiran LiCenter of Excellence in Neuro-Oncology Sciences (CENOS), St. Jude Children's Research Hospital, Memphis, TN, USA; Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Melissa BattsCenter of Excellence in Neuro-Oncology Sciences (CENOS), St. Jude Children's Research Hospital, Memphis, TN, USA; Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Priya MittalCenter of Excellence in Neuro-Oncology Sciences (CENOS), St. Jude Children's Research Hospital, Memphis, TN, USA; Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Stephanie C WuCenter of Excellence in Neuro-Oncology Sciences (CENOS), St. Jude Children's Research Hospital, Memphis, TN, USA; Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Sara A LewisCenter of Excellence in Neuro-Oncology Sciences (CENOS), St. Jude Children's Research Hospital, Memphis, TN, USA; Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Katie HanCenter of Excellence in Neuro-Oncology Sciences (CENOS), St. Jude Children's Research Hospital, Memphis, TN, USA; Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Taha SolimanCenter of Excellence in Neuro-Oncology Sciences (CENOS), St. Jude Children's Research Hospital, Memphis, TN, USA; Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Hong LinCenter of Excellence in Neuro-Oncology Sciences (CENOS), St. Jude Children's Research Hospital, Memphis, TN, USA; Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Laure JankeDepartment of Pathology, Neuropathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
David MeredithDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Elke PfaffHopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.
Johannes GojoCenter for Cancer Research and Comprehensive Cancer Center, Medical University Vienna, Vienna, Austria; Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.
Jennifer CotterKeck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Paul KlimoDepartment of Surgery, St. Jude Children's Research Hospital, Memphis, TN, USA; Department of Neurosurgery, Le Bonheur Children's Hospital, Memphis, TN, USA.
Frederick A BoopDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, USA; Department of Neurosurgery, University of Tennessee Health Science Center, Memphis, TN, USA.
Amar GajjarDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Giles W RobinsonDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Gabriela RosénDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
Sanda AlexandrescuDepartment of Pathology, Boston Children's Hospital, Boston, MA, USA.
David T W JonesHopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
Brent A OrrDepartment of Pathology, Neuropathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Fredrik J SwartlingDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
Mariella G FilbinDana-Farber/Boston Children's Cancer and Blood Disorders Center; Harvard Medical School, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Paul A NorthcottCenter of Excellence in Neuro-Oncology Sciences (CENOS), St. Jude Children's Research Hospital, Memphis, TN, USA; Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA. Electronic address: paul.northcott@stjude.org.

Funding

Mapping the Cerebellar Origins of Medulloblastoma SubgroupsR01CA270785 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Paul Northcott · 2023 to 2026
$2.8M
Deconstructing pineoblastoma origins to advance disease biology, modeling, and therapyR01CA259372 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Paul Northcott · 2024 to 2026
$1.8M
NCI NIH HHS R01 CA259372NCI NIH HHS R01 CA270785
6 · The paper itself

Abstract

Pineoblastoma is a clinically aggressive childhood brain tumor composed of distinct molecular subgroups with divergent driver genes, demographics, and clinical outcomes. To identify developmental origins and mechanisms governing disease pathogenesis, we derive single-cell transcriptomes from pineal parenchymal tumors, aligning malignant cells with developmental counterparts to retrace cellular origins. Integrative computational analyses map pineoblastoma origins to transient, cycling pinealocyte progenitors during development. Lineage-specific perturbation of suspected drivers in the early pineal gland yields preclinical models representative of consensus molecular subgroups. Multi-omic characterization of patient tumors and these models uncover a tumor-associated photoreceptor signature (TAPS) common to pineoblastoma, retinoblastoma, and Group 3 medulloblastoma. Transcriptional activity of this signature within respective cellular origins establishes a developmental basis for molecular similarities between entities. Photoreceptor signature constituents are selective dependencies across these anatomically distinct central nervous system malignancies, motivating future studies evaluating developmentally encoded programs of malignancy as potential therapeutic liabilities.

Indexed as

Brain NeoplasmsCentral Nervous System NeoplasmsMedulloblastomaPhotoreceptor CellsPinealomaAnimalsGene Expression Regulation, NeoplasticHumansMicePineal GlandRetinoblastomaSingle-Cell Gene Expression AnalysisTranscriptomecentral nervous system cancersdevelopmental originsgenetically engineered mouse modelsgenetic dependenciesmedulloblastomaphotoreceptorpineal glandpineoblastomaretinoblastomasingle-cell genomics

Identifiers

PMID41791379
PMCPMC13123407

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.